Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Evaluation of CD4-CD4i antibody architectures yields potent, broadly cross-reactive anti-human immunodeficiency virus reagents.

West AP Jr, Galimidi RP, Foglesong CP, Gnanapragasam PN, Klein JS, Bjorkman PJ.

J Virol. 2010 Jan;84(1):261-9. doi: 10.1128/JVI.01528-09.

2.

Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10.

Klein JS, Gnanapragasam PN, Galimidi RP, Foglesong CP, West AP Jr, Bjorkman PJ.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7385-90. doi: 10.1073/pnas.0811427106. Epub 2009 Apr 16.

3.

Design and expression of a dimeric form of human immunodeficiency virus type 1 antibody 2G12 with increased neutralization potency.

West AP Jr, Galimidi RP, Foglesong CP, Gnanapragasam PN, Huey-Tubman KE, Klein JS, Suzuki MD, Tiangco NE, Vielmetter J, Bjorkman PJ.

J Virol. 2009 Jan;83(1):98-104. doi: 10.1128/JVI.01564-08. Epub 2008 Oct 22.

Supplemental Content

Loading ...
Support Center